Advertisement
Singapore markets closed
  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     
  • Nikkei

    39,583.08
    +241.54 (+0.61%)
     
  • Hang Seng

    17,718.61
    +2.14 (+0.01%)
     
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • Bitcoin USD

    60,862.83
    +607.20 (+1.01%)
     
  • CMC Crypto 200

    1,266.05
    -17.78 (-1.38%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • Dow

    39,118.86
    -45.20 (-0.12%)
     
  • Nasdaq

    17,732.60
    -126.08 (-0.71%)
     
  • Gold

    2,336.90
    +0.30 (+0.01%)
     
  • Crude Oil

    81.46
    -0.28 (-0.34%)
     
  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     
  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     
  • Jakarta Composite Index

    7,063.58
    +95.63 (+1.37%)
     
  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

Livent Corporation (NYSE:LTHM) Q3 2023 Earnings Call Transcript

Livent Corporation (NYSE:LTHM) Q3 2023 Earnings Call Transcript October 31, 2023

Livent Corporation misses on earnings expectations. Reported EPS is $0.44 EPS, expectations were $0.46.

Operator: Good afternoon, everyone and welcome to the Third Quarter 2023 Earnings Release Conference Call for Livent Corporation. Phone lines will be placed on listen-only mode throughout the conference. After the speakers' presentation, there will be a question-and-answer period. I will now turn the conference over to Mr. Daniel Rosen, Investor Relations and Strategy for Livent Corporation. Mr. Rosen, you may begin.

Daniel Rosen: Great. Thank you, Paul. Good evening, everyone, and welcome to Livent's third quarter 2023 earnings call. Joining me today are Paul Graves, President and Chief Executive Officer; and Gilberto Antoniazzi, Chief Financial Officer. The slide presentation that accompanies our results, along with our earnings release, can be found in the Investor Relations section of our website. Prepared remarks from today's discussion will be made available after the call. Following our prepared remarks, Paul and Gilberto will be available to address your questions. Given the number of participants on the call today, we would request a limit of one question and one follow-up per caller. We'd be happy to address any additional questions after the call.

A closeup of a Petrochemical product being inspected for quality assurance.

ADVERTISEMENT

Before we begin, let me remind you that today's discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to those factors identified in our Form 10-K and other filings with the Securities and Exchange Commission. Information presented represents our best judgment based on today's information. Actual results may vary based upon these risks and uncertainties. Today's discussion will include references to various non-GAAP financial metrics. Definitions of these terms, as well as reconciliation to the most directly comparable financial measure calculated and presented in accordance with GAAP, are provided on our Investor Relations website. And with that, I'll turn the call over to Paul.

Paul Graves: Thank you, Dan. Good evening, everyone. I promise no bad Halloween jokes tonight. I promise. We reported third quarter results that were highlighted by adjusted EBITDA of $120 million, up 8% on a year-over-year basis, with a margin that was roughly flat versus the prior quarter and a nine percentage point higher margin than a year ago. We're providing an update on progress with our multiple capacity expansion projects, including the impact on expected sales volumes over the remainder of 2023 and into 2024. We will touch on the recent feasibility study released for the Nemaska Lithium project in Quebec, which further underscores both the quality of Nemaska's assets as well as its importance in serving growing supply chains in North America.

Finally, we will provide an update on our pending merger with Allkem, including the continued progress that has been made and what you can expect in the coming months as we move to meet the targeted close of around the end of 2023. Before providing some market perspectives and a live business update, I'll turn the call over to Gilberto to discuss our third quarter performance, as well as our revised full year 2023 financial guidance.

See also Top 12 Medical AI Companies and 25 Most Atheist Countries in the World.

To continue reading the Q&A session, please click here.